Skip to content
GLP-1 Savers
Menu
Ranked #330 · Watch List

Levers Health review

Levers Health sells compounded semaglutide from $247 and tirzepatide from $296 on dose-capped plans, plus a separate low-dose and microdose GLP-1 line aimed at longevity rather than weight loss.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $247/mo

Save ~82% vs brand-name

From $247/mo (1.25 mg dose, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The two figures Levers leads with are the LOW-DOSE plans. Semaglutide is from $247 and tirzepatide from $296, but the tirzepatide any-dose plan is $396 - so the headline holds only while your dose stays under 5 mg, and titrating past it is a $100 jump rather than a gradual one.

How much does Levers Health cost?

The price Levers Health publishes is From $247/mo (1.25 mg dose, compounded). Tirzepatide is listed at From $296/mo (5 mg dose, compounded). We flag this one to watch: confirm the ongoing rate with Levers Health before you count on it, because a low first month can step up afterward. That works out about 82% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $247/mo (1.25 mg dose, compounded)
Tirzepatide
From $296/mo (5 mg dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Levers Health scored on our six published factors. See the methodology.

Lowest Real Price62/100
No Teaser-Rate Bait64/100
Nationwide Availability45/100
Both Molecules92/100
Easy Cancellation58/100
Reputation68/100

Why it's a deal

  • Runs a distinct low-dose and microdose GLP-1 line for metabolic optimization, which most weight-loss sellers do not offer separately
  • Prices for each plan are published on the storefront rather than quoted after an intake
  • Both molecules are available alongside sermorelin on the same account

Read the fine print

  • The advertised $296 tirzepatide plan caps at 5 mg — the any-dose plan is $396, so the headline does not survive titration
  • $247 semaglutide is above the roughly $179 median tracked here before any dose step-up
  • No LegitScript or PCAB accreditation is displayed, and no physical address is published
  • Neither the FAQ nor the terms page loads, so the cancellation and refund terms cannot be read before signing up
  • The states it serves are not disclosed

The bottom line

Best for: Someone staying on a low dose, or specifically looking for a microdose protocol. Levers Health sells compounded semaglutide from $247 and tirzepatide from $296 on dose-capped plans, plus a separate low-dose and microdose GLP-1 line aimed at longevity rather than weight loss.

Ranked #330 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Levers Health, out of 426 others we track.

Shopping Levers Health against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Levers Health, and every program that undercuts or outscores it — starting with Genesis Health, the closest match on score — is ranked on the Levers Health alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Levers Health's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Levers Health's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals